First half 2020 results presentation

Operating income, growth figures, profitability and how our products have behaved.


No votes yet
 
Relacionados
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) ha anunciado la compra de Falithrom®, propiedad de Hexal AG (“Hexal”), una compañía de la...
1 min
09/01/2019